Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

In vitro activity of new glycopeptide from Lilly

July 25, 1997

HRT indicated in hypertensive women

July 25, 1997

HRT inhibits ACE in postmenopausal women

July 25, 1997

New bactericidal antiseptic from Otsuka

July 24, 1997

Potent, orally active azole antifungal from Bayer

July 24, 1997

Quinolones remain at the forefront of antiinfective therapy

July 24, 1997

Antibacterial activity and clinical efficacy of grepafloxacin reported

July 24, 1997

More light shed on leptin and leptin receptors

July 24, 1997

Genetic and molecular pathogenesis of IDDM

July 24, 1997

DU-6859a: dose-finding study in UTI

July 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...